000 | 01723 a2200445 4500 | ||
---|---|---|---|
005 | 20250517201810.0 | ||
264 | 0 | _c20180723 | |
008 | 201807s 0 0 eng d | ||
022 | _a1178-1998 | ||
024 | 7 |
_a10.2147/CIA.S152701 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYang, Pei-Shan | |
245 | 0 | 0 |
_aAn open-label, prospective interventional study of the tolerability and efficacy of 0.4 mg oral tamsulosin oral controlled absorption system in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with treatment with 0.2 mg tamsulosin. _h[electronic resource] |
260 |
_bClinical interventions in aging _c2018 |
||
300 |
_a235-242 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase IV; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aDrug Tolerance |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLower Urinary Tract Symptoms _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPatient Satisfaction |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aProstatic Hyperplasia _xcomplications |
650 | 0 | 4 | _aQuality of Life |
650 | 0 | 4 |
_aSulfonamides _xadministration & dosage |
650 | 0 | 4 | _aTamsulosin |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aUrination _xdrug effects |
650 | 0 | 4 |
_aUrological Agents _xadministration & dosage |
700 | 1 | _aChen, Chien-Lun | |
700 | 1 | _aHou, Chen-Pang | |
700 | 1 | _aLin, Yu-Hsiang | |
700 | 1 | _aTsui, Ke-Hung | |
773 | 0 |
_tClinical interventions in aging _gvol. 13 _gp. 235-242 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2147/CIA.S152701 _zAvailable from publisher's website |
999 |
_c28087593 _d28087593 |